Research / ALSN / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-055372 General Corporate
Debt relative to revenue 38th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
342.39% · OPTIONAL · VALID
Capex intensity 38th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.08% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.80% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
3.66% · CORE · VALID
Inventory pressure 85th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.18% · OPTIONAL · VALID
Gross margin 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
48.51% · CORE · VALID
Operating margin 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
30.16% · CORE · VALID
R&D intensity 46th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.66% · OPTIONAL · VALID
SBC intensity 69th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.82% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 322.09%
Current 342.39%
Delta 20.30% Capex Intensity Increased
Previous 2.43%
Current 4.08%
Delta 1.65% Cash Generation Increased
Previous 18.01%
Current 28.80%
Delta 10.80% Growth Decreased
Previous 17.92%
Current 3.66%
Delta -14.26% Inventory Pressure Increased
Previous 35.50%
Current 38.18%
Delta 2.67% Margin Decreased
Previous 48.66%
Current 48.51%
Delta -0.15% Profitability Decreased
Previous 30.91%
Current 30.16%
Delta -0.74% R And D Intensity Increased
Previous 6.00%
Current 6.66%
Delta 0.66% Sbc Intensity Increased
Previous 0.77%
Current 0.82%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.